Novel Treatment of Advanced Hepatocellular Carcinoma
Status:
Recruiting
Trial end date:
2023-04-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of arginine hydrochloride
combined with Levamisole in the treatment of patients with hepatocellular carcinoma.
Phase:
Phase 3
Details
Lead Sponsor:
The First Affiliated Hospital of Zhengzhou University
Collaborators:
Anyang Tumor Hospital Luoyang Central Hospital Nanyang Central Hospital Pingdingshan Coal Medical Group General Hospital Sanmenxia Central Hospital The Third People's Hospital of Jiaozuo